Xinfeng Qu

702 total citations
37 papers, 476 citations indexed

About

Xinfeng Qu is a scholar working on Epidemiology, Surgery and Microbiology. According to data from OpenAlex, Xinfeng Qu has authored 37 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 14 papers in Surgery and 10 papers in Microbiology. Recurrent topics in Xinfeng Qu's work include Cervical Cancer and HPV Research (34 papers), Genital Health and Disease (10 papers) and Reproductive tract infections research (10 papers). Xinfeng Qu is often cited by papers focused on Cervical Cancer and HPV Research (34 papers), Genital Health and Disease (10 papers) and Reproductive tract infections research (10 papers). Xinfeng Qu collaborates with scholars based in China, United States and Hong Kong. Xinfeng Qu's co-authors include Hui Du, Jerome L. Belinson, Ruifang Wu, Chun Wang, Suzanne Belinson, Bin Yang, Robert G. Pretorius, Xia Huang, Lijie Zhang and Ruifang Wu and has published in prestigious journals such as PLoS ONE, Journal of Clinical Epidemiology and International Journal of Cancer.

In The Last Decade

Xinfeng Qu

33 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinfeng Qu China 12 440 134 127 105 101 37 476
Nicole J. Polman Netherlands 10 455 1.0× 149 1.1× 100 0.8× 98 0.9× 157 1.6× 14 502
Susanne Rehm United States 5 364 0.8× 177 1.3× 69 0.5× 47 0.4× 107 1.1× 5 410
Roger Dachez France 11 533 1.2× 302 2.3× 134 1.1× 82 0.8× 122 1.2× 28 671
Severien Van Keer Belgium 17 542 1.2× 64 0.5× 201 1.6× 134 1.3× 170 1.7× 32 594
Renée M.F. Ebisch Netherlands 10 416 0.9× 147 1.1× 80 0.6× 61 0.6× 139 1.4× 24 477
Κimon Chatzistamatiou Greece 11 283 0.6× 124 0.9× 63 0.5× 39 0.4× 73 0.7× 38 365
Qin‐Jing Pan China 11 347 0.8× 156 1.2× 63 0.5× 86 0.8× 93 0.9× 14 424
Claire Thomson United Kingdom 4 411 0.9× 217 1.6× 71 0.6× 62 0.6× 112 1.1× 6 461
Baowen Zheng China 10 299 0.7× 153 1.1× 52 0.4× 61 0.6× 42 0.4× 19 375
Grazyna Stanczuk Zimbabwe 13 442 1.0× 114 0.9× 141 1.1× 80 0.8× 153 1.5× 18 574

Countries citing papers authored by Xinfeng Qu

Since Specialization
Citations

This map shows the geographic impact of Xinfeng Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinfeng Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinfeng Qu more than expected).

Fields of papers citing papers by Xinfeng Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinfeng Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinfeng Qu. The network helps show where Xinfeng Qu may publish in the future.

Co-authorship network of co-authors of Xinfeng Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinfeng Qu. A scholar is included among the top collaborators of Xinfeng Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinfeng Qu. Xinfeng Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Belinson, Jerome L., Hui Du, Changzhong Li, et al.. (2024). AmpFire HPV and ScreenFire RS HPV validation trial. American Journal of Clinical Pathology. 161(6). 535–542. 5 indexed citations
3.
Zhang, Yi, Hui Du, Chun Wang, et al.. (2024). Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial. Infectious Agents and Cancer. 19(1). 16–16. 1 indexed citations
4.
Du, Hui, et al.. (2024). Performance of P16INK4a immunocytochemical stain in facilitating cytology interpretation of HSIL for HPV-positive women aged 50 and above. Frontiers in Oncology. 14. 1332172–1332172. 1 indexed citations
5.
Du, Hui, Xinfeng Qu, Chunlei Guo, et al.. (2023). Application an internet facilitation in a community-based cervical cancer screening project. BMC Women s Health. 23(1). 641–641.
6.
Soler, Montserrat, Karla Alfaro, Rachel Masch, et al.. (2022). Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. JCO Global Oncology. 8(8). e2200112–e2200112. 4 indexed citations
7.
Guo, Chunlei, Hui Du, Xinfeng Qu, et al.. (2022). Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST. Frontiers in Public Health. 10. 840879–840879. 6 indexed citations
8.
Yang, Qing, Hui Du, Xinfeng Qu, et al.. (2022). Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening. Frontiers in Public Health. 10. 1010066–1010066.
9.
Song, Fangbin, Peisha Yan, Xia Huang, et al.. (2022). Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination. BMC Cancer. 22(1). 42–42. 19 indexed citations
10.
Song, Fangbin, Peisha Yan, Xia Huang, et al.. (2021). Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China. BMC Infectious Diseases. 21(1). 400–400. 13 indexed citations
11.
Du, Hui, Hongxue Luo, Chun Wang, et al.. (2021). The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features. Journal of Clinical Epidemiology. 139. 319–329. 10 indexed citations
12.
Guo, Chunlei, Hui Du, Jerome L. Belinson, et al.. (2021). The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women. Infectious Agents and Cancer. 16(1). 21–21. 11 indexed citations
13.
14.
Du, Hui, Chun Wang, Xia Huang, et al.. (2020). The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer. PLoS ONE. 15(5). e0232117–e0232117. 18 indexed citations
15.
Song, Fangbin, Hui Du, Chun Wang, et al.. (2020). The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening. Journal of Medical Screening. 28(3). 318–324. 10 indexed citations
16.
Wu, Ruifang, Xinfeng Qu, Hui Du, et al.. (2016). A Pilot Study to Evaluate an Internet-Based Cervical Cancer Screening Model Based on Self-Sampling. Health. 8(7). 672–679. 5 indexed citations
17.
Maurer, Kathryn A., Hongxue Luo, Zhiyong Shen, et al.. (2016). Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical cancer prevention. Journal of Clinical Virology. 76. 14–19. 11 indexed citations
18.
Luo, Hongxue, Hui Du, Kathryn A. Maurer, et al.. (2016). An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media. PLoS ONE. 11(2). e0148168–e0148168. 8 indexed citations
19.
Belinson, Jerome L., Hui Du, Bin Yang, et al.. (2011). Improved sensitivity of vaginal self‐collection and high‐risk human papillomavirus testing. International Journal of Cancer. 130(8). 1855–1860. 81 indexed citations
20.
Belinson, Jerome L., Ruifang Wu, Suzanne Belinson, et al.. (2011). A Population-Based Clinical Trial Comparing Endocervical High-Risk HPV Testing Using Hybrid Capture 2 and Cervista From the SHENCCAST II Study. American Journal of Clinical Pathology. 135(5). 790–795. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole J. Polman Breakdown of academic impact, for papers by Susanne Rehm Breakdown of academic impact, for papers by Roger Dachez Breakdown of academic impact, for papers by Severien Van Keer Breakdown of academic impact, for papers by Renée M.F. Ebisch Breakdown of academic impact, for papers by Κimon Chatzistamatiou Breakdown of academic impact, for papers by Qin‐Jing Pan Breakdown of academic impact, for papers by Claire Thomson Breakdown of academic impact, for papers by Baowen Zheng Breakdown of academic impact, for papers by Grazyna Stanczuk
Rankless by CCL
2026